L 198/80 Official Journal of the European Union 30.7.2009 COMMISSION DECISION of 29 July 2009 allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, benalaxyl-M, mandipropamid, novaluron, proquinazid, spirodiclofen and spiromesifen (notified under document number C(2009) 5582) (Text with EEA relevance) (2009/579/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market ('), and in particular the fourth subparagraph of Article 8(1) thereof, Whereas: 1) In accordance with Article 6(2) of Directive 91/414/EEC, in March 2001 the United Kingdom received an appli- cation from Makhteshim Agan Ltd. for the inclusion of the active substance novaluron in Annex I to Directive 91/414[/EEC. Commission Decision 2001/861/EC (?) confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex Il and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in August 2001 the Netherlands received an application from Bayer AG, Germany for the inclusion of the active substance spirodiclofen in Annex I to Directive 91/414[/EEC. Commission Decision 2002/593/EC (?) confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex Il and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in February 2002 Portugal received an application from ISAGRO IT for the inclusion of the active substance benalaxyl-M in Annex I to Directive 91/414/EEC. Commission Decision 2003/35/EC () confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex Il and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in April 2002 the United Kingdom received an appli- cation from Bayer AG for the inclusion of the active substance  spiromesifen in Annex [ to Directive 91/414[/EEC. Commission Decision 2003/105/EC (°) 230, 19.8.1991, p. 1. 321, 6.12.2001, p. 34. 11, 16.1.2003, p. 52. 43, 18.2.2003, p. 45. () oL () oL () OJ L 192, 20.7.2002, p. 60. () oL () oL confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex I and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in March 2003 the Netherlands received an application from Agro-Kanesho Co. Ltd for the inclusion of the active substance acequinocyl in Annex I to Directive 91/414/EEC. Commission Decision 2003/636/EC (°) confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex I and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in January 2004 the United Kingdom received an appli- cation from DuPont (UK) Ltd for the inclusion of the active substance proquinazid in Annex I to Directive 91/414/EEC. Commission Decision 2004/686/EC (7) confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in September 2004 the Netherlands received an appli- cation from Citrex Nederland BV for the inclusion of the active substance ascorbic acid in Annex I to Directive 91/414/EEC. Commission Decision 2005/751/EC (}) confirmed that the dossier was complete and could be considered as satisfying, in prin- ciple, the data and information requirements of Annex II and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in September 2004 the United Kingdom received an application from Dow AgroSciences for the inclusion of the active substance aminopyralid in Annex I to Directive 91/414/EEC. Commission Decision 2005/778[EC (°) confirmed that the dossier was complete and could be considered as satisfying, in prin- ciple, the data and information requirements of Annex II and Annex III to that Directive. 221, 4.9.2003, p. 42. 313, 12.10.2004, p. 21. ) oL () O L (% O] L 282, 26.10.2005, p. 18. () O L 293, 9.11.2005, p. 26.